• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Dermatology Times 2023 In Review: Acne

News
Article

As 2023 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in acne this year.

New Pediatric Perspectives for Acne

Experts at Maui Derm Hawaii offer the latest findings and research in treating acne vulgaris in adolescents.

Preadolescent Acne Linked to Higher Body Mass Index

A new study also explores why the incidence of acne vulgaris is higher in girls than boys.

Sarecycline’s Lipophilicity May Explain Lower Rates of Adverse Events

Study investigators evaluated the blood-brain barrier penetrance and lipophilicity of the narrow-spectrum, third-generation tetracycline-class oral antibiotic used for acne treatment.

Patients May be Under-Prescribed Isotretinoin Based on Gender Identity

Transgender and cisgender patients presenting with acne face differences in acne treatment and prescribing patterns.

Silybum Marianum Fruit Extract Safe, Effective in Acne-Prone Skin

Researchers say adolescents and young adults using the dermocosmetic product experienced improvements in their acne and quality of life.

Photoprotection Can Improve Acne Outcomes

Researchers say sun exposure plays a role in the exposome of acne-prone skin.

Microbial Diversity Leads to Successful Isotretinoin Response in Acne

Researchers said the drug successfully altered C. acnes strains and more in a recent study.

Compound Glycyrrhizin Injections More Efficacious in Acne Than Clindamycin

Researchers said using the injections and mesotherapy in patients with acne more effectively treated their acne.

Tranexamic Acid Injections May Be Efficacious in Acne Vulgaris

Researchers said the treatment may improve post-acne erythema.

How to Effectively Manage Acne in Women With Spironolactone and Oral Contraceptives

Julie Harper, MD, shared updated risks and benefits of using spironolactone and oral contraceptives to treat acne in women at SCALE 2023.

Need-To-Know Acne Pearls From Joshua Zeichner, MD

Zeichner reviewed his top 3 acne treatment pearls at the Fall Clinical Dermatology Conference for PAs and NPs.

Tazarotene 0.045% Lotion for Acne Safe, Improves Hyperpigmentation in SOC Patients

A poster presentation from the Fall Clinical Dermatology Conference for PAs and NPs evaluated the safety and efficacy of tazarotene for acne patients with skin of color.

Managing Acne Vulgaris During Pregnancy and Lactation

During pregnancy and lactation, physiological changes occur in the body that can impact the development and management of acne.

Promoting Beneficial Skin Care and Self Care Habits Among Teenagers

With hormonal fluctuations, constantly changing schedules, and various afterschool activities, addressing the specific needs of teenage skin becomes essential to promote a lifetime of proper skin care practices.

Top 5 Clinical Pearls for Acne Vulgaris Management

Catch up on acne vulgaris treatment pearls from Dermatology Times’ most recent Frontline Forum series, featuring James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD.

Research Finds Dermatology Visits for Acne Higher in Adult Female Patients

Yale School of Medicine researchers found tetracycline-class antibiotics were the most prescribed acne treatment for adult female patients between 2002 and 2016.

Acne Conglobata: An Overview and Effective Management Strategies

The impact of acne conglobata on individuals underscores the crucial role dermatologists play in providing effective diagnosis, treatment, and emotional support.

IDP-126 Approved by FDA for Treatment of Acne

The US Food and Drug Administration has approved IDP-126 gel for patients with acne.

Acne Survey Reveals Only 3 in 10 Patients Have Gone to a Dermatologist for Treatment

The Sun Pharma survey included 1003 respondents with mild to moderate acne.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.